Feb 24 (Reuters) - CSL Ltd CSL.AX :
* SEQIRUS RECEIVES FDA APPROVAL FOR FLUAD® QUADRIVALENT (INFLUENZA VACCINE, ADJUVANTED) FOR ADULTS 65 YEARS AND OLDER
Feb 24 (Reuters) - CSL Ltd CSL.AX :
* SEQIRUS RECEIVES FDA APPROVAL FOR FLUAD® QUADRIVALENT (INFLUENZA VACCINE, ADJUVANTED) FOR ADULTS 65 YEARS AND OLDER